Thursday , March 28 2024
Home / SNB & CHF / Companies invest more money in R&D in Switzerland

Companies invest more money in R&D in Switzerland

Summary:
Syngenta employees carry out research on corn in Stein, canton Aargau, in November 2021. © Keystone / Gaetan Bally Firms invested CHF16.8 billion ( billion) in research and development (R&D) activities in Switzerland last year, a 4% increase compared to 2019. A survey carried out by the Federal Statistical Office (FSO) and the Swiss Business Federation economiesuisse said the pharmaceutical sector was the biggest R&D investor (CHF6.2 billion, or 37% of the total). The overall CHF1.3 billion rise since 2019 was in line with a recent upward trend, but it is all the more remarkable given the difficult economic situations in 2020 and 2021 caused by the Covid-19 pandemic, the FSO said in a statement on Monday. Fundamental research fell from around one quarter of

Topics:
Swissinfo considers the following as important: , , , ,

This could be interesting, too:

Connor O'Keeffe writes Is the Violence in Haiti a Preview of a Libertarian Society?

Douglas French writes Tapping 401ks to Pay the Bills

Marc Chandler writes Dollar Extends Gains Against the Yen but Broadly Firmer Ahead of the FOMC

Grey Haneberg writes Reimagining Public Safety – The Case for Privatizing Security

Companies invest more money in R&D in Switzerland

Syngenta employees carry out research on corn in Stein, canton Aargau, in November 2021. © Keystone / Gaetan Bally

Firms invested CHF16.8 billion ($18 billion) in research and development (R&D) activities in Switzerland last year, a 4% increase compared to 2019.

A survey carried out by the Federal Statistical Office (FSO) and the Swiss Business Federation economiesuisse said the pharmaceutical sector was the biggest R&D investor (CHF6.2 billion, or 37% of the total).

The overall CHF1.3 billion rise since 2019 was in line with a recent upward trend, but it is all the more remarkable given the difficult economic situations in 2020 and 2021 caused by the Covid-19 pandemic, the FSO said in a statement on Monday.

Fundamental research fell from around one quarter of companies’ overall research investment in 2015 to 8% in 2021. This is mainly due to changes in the type of research carried out within pharmaceutical companies, the FSO said.

Looking at the different specialist fields, R&D investment in biotechnology has steadily increased since 2012, the statistics office said. In 2021, companies invested CHF5.9 billion in this area, or 35% of total R&D spending.

Firms invested CHF6.3 billion on R&D abroad – a slight decrease – the FSO said.

“After strong growth between 2012 and 2017, the current trend seems to show that companies are finding in Switzerland the means to meet their own R&D needs,” it said.

Last year, companies employed nearly 62,000 people working on R&D, an annual increase of 2% since 2019. A quarter of all research staff were women, a percentage that has remained the same over the past ten years.

More: SWI swissinfo.ch certified by the Journalism Trust Initiative


Tags: ,,
About Swissinfo
Swissinfo
SWI swissinfo.ch – the international service of the Swiss Broadcasting Corporation (SBC). Since 1999, swissinfo.ch has fulfilled the federal government’s mandate to distribute information about Switzerland internationally, supplementing the online offerings of the radio and television stations of the SBC. Today, the international service is directed above all at an international audience interested in Switzerland, as well as at Swiss citizens living abroad.

Leave a Reply

Your email address will not be published. Required fields are marked *